6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
20m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
20m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
20m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
20m ago	First Quantum Minerals Reports First Quarter 2026 Results
20m ago	District Metals Announces $10 Million Private Placement Financing

About

Entrada Therapeutics Inc (NASDAQ:TRDA) — investor relations, events, news, and company updates on 6ix.

Latest News

Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study

Entrada Therapeutics to Present at Upcoming Investor Conferences

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Financials

Revenue

$25.42 M

Market Cap

$503.44 M

EPS

-3.47

Community Chat

Ask AI